Lattice radiation therapy for large tumors
Part of Cancer clinical trials.
This trial tests a new way of giving radiation therapy called lattice radiotherapy (LRT) for people with large tumors that cannot be cured with standard treatments. It aims to deliver high doses of radiation to the center of the tumor while sparing surrounding healthy tissue, potentially controlling the tumor and improving quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed cancer diagnosis (from a biopsy or other tissue test).
- Your cancer must be advanced or locally advanced, meaning it cannot be treated with curative intent.
- You need to have at least one tumor outside the brain that measures 4.5 cm or larger in any direction.
- You must be in reasonably good health (performance status 0-2 on the ECOG scale, meaning you can do most daily activities).
- If you could become pregnant, you must have a negative pregnancy test before starting treatment and use effective birth control during and for 30 days after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to deliver radiation called lattice therapy for people with large solid tumors that are causing symptoms. It aims to give a stronger radiation dose to help shrink the tumor and relieve discomfort.
This trial tests a special type of radiation called Lattice Radiotherapy (LRT) for adults with large tumors (at least 4.5 cm) that have spread or started outside the brain. It aims to shrink tumors and relieve symptoms.
This trial tests a special type of focused radiation therapy (called SBRT-Lattice) for large tumors in patients who can't benefit from surgery, chemotherapy, or standard radiation. The radiation uses a lattice pattern designed to treat the tumor while protecting healthy tissue nearby.
This phase 3 trial tests a newer radiation technique called Lattice Radiation Therapy against standard radiation for people with large solid tumors (over 5 cm) that cannot be removed by surgery or treated with standard radiation. The goal is to see if the newer approach provides better pain relief and tumor control.
This trial tests whether adding a special radiotherapy technique called lattice radiotherapy to your usual cancer treatment can help control NSCLC that has started to grow in a few new spots. If you have up to 5 growing tumors and at least one measures 4.5 cm or larger, this study might be an option.
This study tests a newer radiation technique called LATTICE radiotherapy compared to standard radiation for treating cancer tumors that have spread to other parts of the body. The goal is to see if the new approach works better and causes fewer side effects.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.